ROBINS CHAD M
SEC CIK 1780649 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | CEO, COB, Dir | 2.46M | — | $50.27M | 25 | 2021-07-12 | 2026-08-17 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-19 20:15 | 2026-08-17+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.55 | +600.0K | 2.46M | +32% | +$3.93M |
| DM | 2026-08-19 20:15 | 2026-08-17+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $24.80 | -600.0K | 2.18M | -22% | -$14.88M |
| MT | 2026-04-08 19:51 | 2026-04-06+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $14.65 | -120.6K | 2.18M | -5% | -$1.77M |
| M | 2026-03-13 | 2026-03-11 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $13.17 | -470.2K | 2.63M | -15% | -$6.19M |
| M | 2026-03-06 | 2026-03-04+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +837.0K | 2.06M | +68% | $0 |
| M | 2026-03-03 | 2026-02-27+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $15.85 | -525.0K | 1.93M | -21% | -$8.32M |
| 2026-02-04 | 2026-02-02 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $18.44 | -125.0K | 2.46M | -5% | -$2.30M | |
| 2026-01-07 | 2026-01-05 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $15.59 | -125.0K | 2.58M | -5% | -$1.95M | |
| M | 2025-12-01 | 2025-11-26+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $19.10 | -160.7K | 2.83M | -5% | -$3.07M |
| M | 2025-11-12 | 2025-11-10+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $14.73 | -89.3K | 2.87M | -3% | -$1.32M |
| M | 2025-03-06 | 2025-03-04+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +602.1K | 3.06M | +24% | $0 |
| M | 2025-03-06 | 2025-03-05+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $7.29 | -219.6K | 2.96M | -7% | -$1.60M |
| DM | 2025-02-21 | 2025-02-19+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.32 | +285.2K | 2.68M | +12% | +$1.80M |
| DM | 2025-02-21 | 2025-02-19+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $8.45 | -285.2K | 2.58M | -10% | -$2.41M |
| DM | 2025-02-18 | 2025-02-13+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.32 | +470.4K | 2.74M | +21% | +$2.97M |
| DM | 2025-02-18 | 2025-02-13+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $8.47 | -470.4K | 2.58M | -15% | -$3.99M |
| M | 2024-03-06 | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $3.43 | -48.7K | 2.58M | -2% | -$167.0K |
| 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +354.6K | 2.63M | +16% | $0 | |
| 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +354.6K | 2.27M | +19% | $0 | |
| DM | 2022-03-09 | 2022-03-07+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.32 | -14.8K | 1.93M | -0.8% | -$93.6K |
| DM | 2022-03-09 | 2022-03-07+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $11.80 | -44.4K | 1.92M | -2% | -$524.4K |
| 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +247.1K | 1.92M | +15% | $0 | |
| 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $12.01 | -4,424 | 1.92M | -0.2% | -$53.1K | |
| M | 2021-09-10 | 2021-09-08+ | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $38.43 | -43.5K | 1.67M | -3% | -$1.67M |
| 2021-07-14 | 2021-07-12 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $38.24 | -1,501 | 1.72M | -0.1% | -$57.4K |
Purchase Sale Sale after option exercise All abbreviations